These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1834847)

  • 1. The unique binding properties of amlodipine: a long-acting calcium antagonist.
    Nayler WG; Gu XH
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)[3H]amlodipine binding to rat cardiac membranes.
    Nayler WG; Gu XH
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):587-92. PubMed ID: 1711625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular and myocardial effects of amlodipine: an overview.
    Nayler WG; Gu XH
    Postgrad Med J; 1991; 67 Suppl 5():S41-3. PubMed ID: 1839439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
    Ishii A; Nishida K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Mason RP; Moisey DM; Shajenko L
    Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization.
    Zobrist RH; Mecca TE
    J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual inhibition in density of [3H]isradipine binding sites in rat brain membrane pretreated with amlodipine.
    Qu YL; Takamizawa C; Sugiyama K; Maruyama K; Hattori K; Watanabe K; Nagatomo T
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):289-93. PubMed ID: 7668092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
    Rampe D; Poder T; Zhao ZY; Schilling WP
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
    Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
    Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
    Ishii A; Toyama J
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine: a once daily calcium antagonist.
    Burges RA
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():49-54. PubMed ID: 1834846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
    Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
    J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.